152 related articles for article (PubMed ID: 14678287)
1. Stimulation of thyroid-stimulating hormone (TSH) receptor antibody production following painless thyroiditis.
Iitaka M; Morgenthaler NG; Momotani N; Nagata A; Ishikawa N; Ito K; Katayama S; Ito K
Clin Endocrinol (Oxf); 2004 Jan; 60(1):49-53. PubMed ID: 14678287
[TBL] [Abstract][Full Text] [Related]
2. Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor.
Morgenthaler NG; Nagata A; Katayama S; Bergmann A; Iitaka M
Clin Endocrinol (Oxf); 2002 Aug; 57(2):193-8. PubMed ID: 12153597
[TBL] [Abstract][Full Text] [Related]
3. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor.
Kamijo K
Endocr J; 2003 Feb; 50(1):113-6. PubMed ID: 12733717
[TBL] [Abstract][Full Text] [Related]
4. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
5. A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves' disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells.
Kamijo K; Murayama H; Uzu T; Togashi K; Kahaly GJ
Thyroid; 2010 Aug; 20(8):851-6. PubMed ID: 20615137
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
7. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Izumi Y; Takeoka K; Amino N
Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
[TBL] [Abstract][Full Text] [Related]
10. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
11. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith.
Kamijo K; Ishikawa K; Tanaka M
Endocr J; 2005 Oct; 52(5):525-9. PubMed ID: 16284428
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
Cho BY; Shong MH; Yi KH; Lee HK; Koh CS; Min HK
Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
[TBL] [Abstract][Full Text] [Related]
14. Painless thyroiditis mimicking relapse of hyperthyroidism during or after potassium iodide or thionamide therapy for Graves' disease resulting in remission.
Okamura K; Sato K; Fujikawa M; Bandai S; Ikenoue H; Kitazono T
Endocr J; 2023 Feb; 70(2):207-222. PubMed ID: 36351595
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
[TBL] [Abstract][Full Text] [Related]
16. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
17. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
18. Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment.
Wallaschofski H; Miehle K; Mayer A; Tuschy U; Hentschel B; Paschke R
Horm Metab Res; 2002 Jul; 34(7):383-8. PubMed ID: 12189586
[TBL] [Abstract][Full Text] [Related]
19. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation.
Allelein S; Diana T; Ehlers M; Kanitz M; Hermsen D; Schott M; Kahaly GJ
Horm Metab Res; 2019 Jun; 51(6):341-346. PubMed ID: 31207654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
